Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$80.66 +0.96 (+1.20%)
As of: Oct 22, 2026 · 2:42 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Ending Cash Balance (2017 - 2026)

Updated

Analysis

Kiniksa Pharmaceuticals International (KNSA) Ending Cash Balance (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn 6.57 Bn
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn 4.88 Bn
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 1.03 Bn
10 Kiniksa Pharmaceuticals International 6.28 Bn 5.02 Bn 220.03 Mn 175.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 175.68 Mn
Mar 31, 2026 189.95 Mn
Dec 31, 2025 165.60 Mn
Sep 30, 2025 174.86 Mn
Jun 30, 2025 192.04 Mn
Mar 31, 2025 157.13 Mn
Dec 31, 2024 183.58 Mn
Sep 30, 2024 97.38 Mn
Jun 30, 2024 99.27 Mn
Mar 31, 2024 141.08 Mn
Dec 31, 2023 107.95 Mn
Sep 30, 2023 117.83 Mn
Jun 30, 2023 112.57 Mn
Mar 31, 2023 80.62 Mn
Dec 31, 2022 122.72 Mn
Sep 30, 2022 175.76 Mn
Jun 30, 2022 94.31 Mn
Mar 31, 2022 63.32 Mn
Dec 31, 2021 122.47 Mn
Sep 30, 2021 190.18 Mn
API Access

Kiniksa Pharmaceuticals International Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=KNSA&period=max&api_key=YOUR_API_KEY